CIK 0000873303
- Large accelerated filer
Sarepta Therapeutics, Inc.
Sign in to watch- Ticker
- SRPT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 930797222
- Phone
- +1 617-274-4000
- Business address
- 215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, 02142
- Former names
- Sarepta Therapeutics, Inc., AVI BIOPHARMA INC, ANTIVIRALS INC
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 46,170 shares at an average $108.28 ($4,999,230)
- 4 Grant or award Director acquired 4,908 shares (grant or award)
- 4 Grant or award Director acquired 4,908 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes SVP, General Counsel gave up 54 shares (to pay taxes)
- 4 Grant or award Director acquired 2,953 shares (grant or award)
- 4 Grant or award Director acquired 2,953 shares (grant or award)
- 4 Grant or award Director acquired 2,953 shares (grant or award)
- 4 Grant or award Director acquired 2,953 shares (grant or award)
- 4 Grant or award Director acquired 2,953 shares (grant or award)
- 4 Grant or award Director acquired 2,953 shares (grant or award)
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,706 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, General Counsel gave up 1,289 shares (to pay taxes)
- 4 Shares withheld for taxes EVP gave up 1,160 shares (to pay taxes)
- 4 Shares withheld for taxes Head of R&D, CSO gave up 1,216 shares (to pay taxes)
- 4 Shares withheld for taxes Head of R&D, CSO gave up 572 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 376 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, General Counsel gave up 184 shares (to pay taxes)
Page 9 of 34 · 672 filings